Skip to main content

Josep Castellví Vives

Institutions of which they are part

Senior researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Josep Castellví Vives

Institutions of which they are part

Senior researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Oncologia Translacional

IP: Jaume Reventós Puigjaner
Collaborators: Soledad Gallego Melcón, Manuel López Cano, José Placer Santos, Josep Sánchez de Toledo Codina, Joan Morote Robles, Ma Teresa Quiles Pérez, Maria Asuncion Perez Benavente, Eva Colas Ortega, Miguel Segura Ginard, Manuel Armengol Carrasco, Josep Castellví Vives, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Maria Antonia Arbos Via, Jacques Planas Morin, Josep Roma Castanyer
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 57200
Reference: 2009 SGR 487
Duration: 01/01/2010 - 30/04/2014

Identificación de marcadores tumorales del adenocarcinoma endometrial a partir de un papel de 297 secuencias diferencialmente expresadas halladas por hibridación de Microarrays.

IP: Angel García Jiménez
Collaborators: Josep Castellví Vives, Antonio Gil Moreno
Funding agency: Instituto de Salud Carlos III
Funding: 65435
Reference: PI020733
Duration: 06/11/2002 - 30/06/2006

Investigación y desarrollo de productos y tecnologías de diagnóstico-pronóstico y aplicaciones terapéuticas en la enfermedad neoplásica.

IP: Jaume Reventós Puigjaner
Collaborators: Francina Munell Casadesus, Josep Castellví Vives, Antonio Gil Moreno
Funding agency: Oncnosis Pharma, AIE
Funding: 249550
Reference: CENIT/01/2006
Duration: 19/01/2006 - 31/12/2009

RTICC - Red Temática de Investigación cooperativa de cáncer

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Matilde Lleonart Pajarin, Cleofé Romagosa Pérez-Portabell, Teresa Moline Marimon, Carmela Iglesias i Felip, Josep Castellví Vives, Elena Antima Martinez Saez, Javier Hernandez Losa, Trond Aasen
Funding agency: Instituto de Salud Carlos III
Funding: 631500.61
Reference: RD06/0020/0104
Duration: 02/01/2007 - 31/12/2014

Related news

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

Related professionals

Martín Huerta García

Martín Huerta García

Research technician
General Surgery
Read more
Stefania Spiliopoulou,

Stefania Spiliopoulou,

Research technician
Physical Medicine and Rehabilitation
Read more
Roger Rica Peiro

Roger Rica Peiro

Technological Infrastructure Unit
Digital Transformation Directorate
Read more
Africa Hontalba Rifa

Africa Hontalba Rifa

Predoctoral researcher
Basic, Translational and Clinical Pharmacy Research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.